Antimicrobial properties of the equine α-defensin DEFA1 against bacterial horse pathogens

Veterinary Immunology and Immunopathology

Volumn 130, Issue 1-2, 2009, Pages 102-106

  Bruhn, O ^a   Cauchard, J ^b   Schlusselhuber, M ^b   Gelhaus, C ^a   Podschun, R ^a   Thaller, G ^a   Laugier, C ^b   Leippe, M ^a   Grotzinger J ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Antimicrobial; DEFA1; Defensin; Horse; Rhodococcus equi

Indexed keywords

ALPHA DEFENSIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL IMMUNITY; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENCY; HORSE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA MULTOCIDA; RHODOCOCCUS EQUI; SALMONELLA CHOLERAESUIS; STREPTOCOCCUS;

ACTINOMYCETALES INFECTIONS; ALPHA-DEFENSINS; AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; HORSE DISEASES; HORSES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PASTEURELLA MULTOCIDA; RECOMBINANT PROTEINS; RHODOCOCCUS EQUI; SALMONELLA; STREPTOCOCCUS;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; FUNGI; MAMMALIA; PASTEURELLA MULTOCIDA; RHODOCOCCUS EQUI; SALMONELLA CHOLERAESUIS;

EID: 67349166128     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.01.005     Document Type: Article

References (27)

1. Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., and Ouellette A.J. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1 (2000) 113-118
2. Bevins C.L., Martin-Porter E., and Ganz T. Defensins and innate host defence of the gastrointestinal tract. Gut 45 (1999) 911-915
3. Bruhn O., Regenhard P., Michalek M., Paul S., Gelhaus C., Jung S., Thaller G., Podschun R., Leippe M., Grötzinger J., and Kalm E. A novel horse α-defensin: gene transcription, recombinant expression and characterization of the structure and function. Biochem. J. 407 (2007) 267-276
4. Daher K.A., Selsted M.E., and Lehrer R.I. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60 (1986) 1068-1074
5. Duvivier D.H., Votion D., Vandenput S., and Lekeux P. Aerosol therapy in the equine species. Vet. J. 154 (1997) 189-202
6. Ferguson, L.R., Browning, B.L., Huebner, C., Petermann, I., Shelling, A.N., Demmers, P., McCulloch, A., Gearry, R.B., Barclay, M.L., Philpott, M., 2008. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Dig. Liver Dis., doi:10.1016/j.dld.2008.02.011.
7. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
8. Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., and Lehrer R.I. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76 (1985) 1427-1435
9. Garcia-Contreras L., Fiegel J., Telko M.J., Elbert K., Hawi A., Thomas M., VerBerkmoes J., Germishuizen W.A., Fourie P.B., Hickey A.J., and Edwards D. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrob. Agents Chemother. 51 (2007) 2830-2836
10. Giacometti A., Cirioni O., Ancarani F., del Prete M.S., Fortuna M., and Scalise G. In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. Antimicrob. Agents Chemother. 43 (1999) 2093-2096
11. Giacometti A., Cirioni O., Kamysz W., Silvestri C., Del Prete M.S., Licci A., D'Amato G., Łukasiak J., and Scalise G. In vitro activity of citropin 1 1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. J. Antimicrob. Chemother. 56 (2005) 410-412
12. Gill S.C., and von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182 (1989) 319-326
13. Jacks S.S., Giguère S., and Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. Antimicrob. Agents Chemother. 47 (2003) 1742-1745
14. Jones S.J., and Spier S.J. In: Equine Internal, Medicine, In: Reed S.M., and Bayly W.M. (Eds). Inflammatory Diseases of the Large Intestine Causing Diarrhea (1998), W. B. Saunders Company, Philadelphia 677 pp
15. Looft C., Paul S., Philipp U., Regenhard P., Kuiper H., Distl O., Chowdhary B.P., and Leeb T. Sequence analysis of a 212 kb defensin gene cluster on ECA 27q17. Gene 376 (2006) 192-198
16. Murray M.J. In: Equine Internal, Medicine, In: Reed S.M., and Bayly W.M. (Eds). Duodenitis-Proximal Jejunitis (1998), W. B. Saunders Company, Philadelphia 623-627
17. Muscatello G., Leadon D.P., Klayt M., Ocampo-Sosa A., Lewis D.A., Fogarty U., Buckley T., Gilkerson J.R., Meijer W.G., and Vazquez-Boland J.A. Rhodococcus equi infection in foals: the science of 'rattles'. Equine Vet. J. 39 (2007) 470-478
18. Porter E.M., van Dam E., Valore E., and Ganz V.T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect. Immun. 65 (1997) 2396-2401
19. Quinn P.J., Markey B.K., Carter M.E., Donnelly W.J., and Leonard F.C. Veterinary Microbiology and Microbial Disease (2001), John Wiley & Sons, Inc., UK
20. Selsted M.E., and Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6 (2005) 551-557
21. Selsted M.E., Szklarek D., Ganz T., and Lehrer R.I. Activity of rabbit leukocyte peptides against Candida albicans. Infect. Immun. 49 (1985) 202-206
22. Soriano F., Fernández-Roblas R., Calvo R., and García-Calvo G. In vitro susceptibilities of aerobic and facultative non-spore-forming Gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob. Agents Chemother. 42 (1998) 1028-1033
23. Tapprest, J., 2008. Retrospective study of Rhodococcus equi infection from a population of 1352 autopsied foals. 4th Havemeyer Rhodococcus equi Workshop, Edinburgh, July 2008.
24. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima Jr. H., Fellermann K., Ganz T., Stange E.F., and Bevins C.L. Reduced Paneth cell α-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18129-18134
25. Wehkamp J., Schwind B., Herrlinger K.R., Baxmann S., Schmidt K., Duchrow M., Wohlschläger C., Feller A.C., Stange E.F., and Fellermann K. Innate immunity and colonic inflammation: enhanced expression of epithelial α-defensins. Dig. Dis. Sci. 47 (2002) 1349-1355
26. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
27. Zhang L., Parente J., Harris S.M., Woods D.E., Hancock R.E.W., and Falla T.J. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. 49 (2005) 2921-2927